DAVISON DANIEL PAUL (Chief Financial Officer) received a stock award from DIPLOMAT PHARMACY, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 4/10/2019ACC: 0001596771-19-000035
Officer· Chief Financial Officer
Since Apr 2019
+330.69K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
330.69K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+43.21K
Price / share
—
Trade value
—
% of position
New position
4/8/2019
0.00→43.21K
Common Stock
Direct
Shares
+200K
Price / share
—
Trade value
—
% of position
462.9%
4/8/2019
43.21K→243.21K
Total
Net shares
+243.21K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/8/2019 | A · Award | +43.21K | — | — | New position | 0.00 | 43.21K |
| Common Stock Direct | 4/8/2019 | A · Award | +200K | — | — | 462.9% | 43.21K | 243.21K |
| Total | +243.21K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option to Acquire Common Stock
Direct
Converts to
Common Stock
87.48K shares
Shares
+87.48K
Strike price
5.78
Held after
87.48K
Exercisable
—
4/8/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option to Acquire Common Stock Direct | Common Stock87.48K shares | 4/8/2019 | A · Award | +87.48K | 5.78 | — | 87.48K |